Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2024-03-11
Product name:
FERINJECT
DIN:
02546078
Product Monograph/Veterinary Labelling:
Date:
2024-06-27
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
VIFOR (INTERNATIONAL) INC.
Rechenstrasse 37
St. Gallen
St Gallen
Switzerland
9014
Class:
Human
Dosage form(s):
Dispersion
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
20:04.04
Anatomical Therapeutic Chemical (ATC): See footnote 4
B03 ANTIANEMIC PREPARATIONS
Active ingredient group (AIG) number:See footnote5
0108536006
| Active ingredient(s) | Strength |
|---|---|
| IRON (FERRIC CARBOXYMALTOSE) | 50 MG / ML |